dalteparin has been researched along with Liver Dysfunction in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a rare case of spontaneous rupture of liver hematoma in patient treated with warfarin end enoxaparin sodium because of pulmonary embolism." | 3.85 | Spontaneous liver rupture associated with anticoagulant therapy A case report. ( Amicucci, G; Clementi, M; Colozzi, S; Della Penna, A; Guadagni, S; Pessia, B; Schietroma, M; Sista, F, 2017) |
| "Hemorrhage was documented in a total of 94 patients (17." | 1.33 | Hemorrhagic complications in patients treated with anticoagulant doses of a low molecular weight heparin (enoxaparin) in routine hospital practice. ( Elis, A; Ellis, MH; Hadari, R; Kovlenko, I; Kozmiakova, M; Shapira, S; Tchuvrero, N; Zissin, R, 2006) |
| "Pretreatment with indomethacin completely reversed both of the therapeutic effects of dalteparin, whereas pretreatment with NS-398, a selective inhibitor of cyclooxygenase-2, did not." | 1.33 | Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. ( Harada, N; Okajima, K; Uchiba, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hui, CK | 1 |
| Yuen, MF | 1 |
| Ng, IO | 1 |
| Tsang, KW | 1 |
| Fong, GC | 1 |
| Lai, CL | 1 |
| Clementi, M | 1 |
| Colozzi, S | 1 |
| Guadagni, S | 1 |
| Pessia, B | 1 |
| Sista, F | 1 |
| Schietroma, M | 1 |
| Della Penna, A | 1 |
| Amicucci, G | 1 |
| Dang, JD | 1 |
| Davis, LE | 1 |
| Thalheimer, U | 1 |
| Triantos, CK | 1 |
| Samonakis, DN | 1 |
| Zambruni, A | 1 |
| Senzolo, M | 1 |
| Leandro, G | 1 |
| Patch, D | 1 |
| Burroughs, AK | 1 |
| Ellis, MH | 1 |
| Hadari, R | 1 |
| Tchuvrero, N | 1 |
| Shapira, S | 1 |
| Kovlenko, I | 1 |
| Kozmiakova, M | 1 |
| Zissin, R | 1 |
| Elis, A | 1 |
| Harada, N | 1 |
| Okajima, K | 1 |
| Uchiba, M | 1 |
| Menger, MD | 1 |
7 other studies available for dalteparin and Liver Dysfunction
| Article | Year |
|---|---|
Low molecular weight heparin-induced liver toxicity.
Topics: Adult; Anticoagulants; Cerebral Infarction; Chemical and Drug Induced Liver Injury; Complement C3; E | 2001 |
Spontaneous liver rupture associated with anticoagulant therapy A case report.
Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fatal Outcome; Hematoma; Hepatectomy; Humans; | 2017 |
Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Topics: Anticoagulants; Blood Coagulation Disorders; Enoxaparin; Hemorrhage; Heparin; Hospitalization; Human | 2015 |
A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood.
Topics: Adult; Aged; Anticoagulants; Artifacts; Blood Specimen Collection; Cholangitis, Sclerosing; Citrates | 2008 |
Hemorrhagic complications in patients treated with anticoagulant doses of a low molecular weight heparin (enoxaparin) in routine hospital practice.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Drug Evaluation; Enoxaparin; Female; Hemorrhag | 2006 |
Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticoagulants; Calcium; Cyclooxygenase 2 Inhibitors; Daltepa | 2006 |
Dalteparin: only protective in hepatic ischemia-reperfusion or also capable of preventing injury in liver hyperperfusion syndrome?
Topics: Animals; Anticoagulants; Dalteparin; Fibrinolytic Agents; Liver; Liver Diseases; Rats; Reperfusion I | 2006 |